(19)
(11) EP 1 309 718 A2

(12)

(88) Date of publication A3:
20.03.2003

(43) Date of publication:
14.05.2003 Bulletin 2003/20

(21) Application number: 01967981.0

(22) Date of filing: 15.08.2001
(51) International Patent Classification (IPC)7C12Q 1/00
(86) International application number:
PCT/US0125/549
(87) International publication number:
WO 0201/8620 (07.03.2002 Gazette 2002/10)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 15.08.2000 US 225628 P
23.08.2000 US 227008 P
22.09.2000 US 234338 P
17.10.2000 US 240806 P
30.11.2000 US 250020 P
16.03.2001 US 276248 P
25.05.2001 US 293499 P
07.06.2001 US 296122 P
13.07.2001 US 304809 P

(71) Applicant: Human Genome Sciences, Inc.
Rockville, MD 20850 (US)

(72) Inventors:
  • YU, Guo-Liang
    Berkeley, CA 94705 (US)
  • EBNER, Reinhard
    Gaithersburg, MD 20878 (US)
  • NI, Jian
    Germantown, MD 20874 (US)
  • ROSEN, Craig, A.
    Laytonsville, MD 20882 (US)
  • ULLRICH, Stephen
    Rockville, MD 20853 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT